Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression

• Ai-Tram N. Bui, BA,
• Caroline A. Nelson, MD,
• Christine G. Lian, MD,
• Alvaro Laga Canales, MD, MMSC,
• Nicole R. LeBoeuf, MD, MPH

Affiliations

Ai-Tram N. Bui, BA

Harvard Medical School, Boston, Massachusetts

Caroline A. Nelson, MD

Department of Dermatology, Yale School of Medicine, New Haven, Connecticut

Christine G. Lian, MD

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts

Alvaro Laga Canales, MD, MMSC

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts

Nicole R. LeBoeuf, MD, MPH

Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts; Correspondence to: Nicole R. LeBoeuf, MD, MPH, Dana-Farber/Brigham and Women's Cancer Center; Center for Cutaneous Oncology; 450 Brookline Avenue; Boston, MA 02115.